4.7 Article

Ambulatory care for constipation in the United States, 1993-2004

期刊

AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 103, 期 7, 页码 1746-1753

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1111/j.1572-0241.2008.01910.x

关键词

-

向作者/读者索取更多资源

OBJECTIVES: Chronic constipation is one of the most common disorders seen in primary care. In order to examine longitudinal changes in the ambulatory care that occur in constipation evaluation and management, we examined national trends in physician office visits associated with constipation between 1993 and 2004. METHODS: Data were derived from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Care Survey (NHAMCS) for 1993-2004. Patient visits were classified as encounters for constipation-related care. Analyses were performed by combining 4 yr of data (1993-1996, 1997-2000, and 2001-2004). RESULTS: Ambulatory visits for constipation increased from 4 million (95% CI 3.3-4.7 million) ambulatory visits for constipation annually during 1993-1996 period to 7.95 million (95% CI 6.6-9.4 million) visits during the 2001-2004 period. The proportion of medical visits for constipation increased for pediatricians, but decreased for adult primary care providers from 1993 to 2004. During the observed time period, the proportion of medical visits for constipation did not change for gastroenterologists. The primary treatment for constipation shifted from bulking agents (fiber) to osmotic laxatives. CONCLUSION: There has been a significant increase in physician office visits for constipation between 1993 and 2004, with the highest rate of increase in the pediatric population. Longitudinal trends indicate an increase in constipation-related visits for pediatricians. The primary treatment for constipation among medical providers shifted from using bulking agents to osmotic laxatives for unknown reasons.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Medicine, General & Internal

Strengthening the presence of Aboriginal and Torres Strait Islander voices in the Medical Journal of Australia

Nicholas J. Talley, Elizabeth Zuccala, Francis Geronimo, Tania Janusic, Elmer V. Villanueva

MEDICAL JOURNAL OF AUSTRALIA (2022)

Editorial Material Medicine, General & Internal

The impact of the MJA continues its rise

Nicholas J. Talley

MEDICAL JOURNAL OF AUSTRALIA (2022)

Editorial Material Medicine, General & Internal

Striving for gender equity at the Medical Journal of Australia

Alisha Dorrigan, Elizabeth Zuccala, Nicholas J. Talley

MEDICAL JOURNAL OF AUSTRALIA (2022)

Article Gastroenterology & Hepatology

Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: Two prospective longitudinal population-based studies

Natasha A. Koloski, Michael Jones, Marjorie M. Walker, Michael Horowitz, Gerald Holtmann, Nicholas J. Talley

Summary: Diabetes is an independent risk factor for an increased frequency of gastrointestinal symptoms, adjusting for lifestyle and psychological factors.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Placebo response in pharmacological trials in patients with functional dyspepsia-A systematic review and meta-analysis

Michelle Bosman, Fabienne Smeets, Sigrid Elsenbruch, Jan Tack, Magnus Simren, Nicholas Talley, Bjorn Winkens, Ad Masclee, Daniel Keszthelyi

Summary: This study conducted a systematic review and meta-analysis to investigate the placebo response in pharmacological trials for functional dyspepsia (FD). The study found that the pooled placebo response rate ranged from 35.5% to 39.6% depending on the responder definition used. Lower baseline symptom scores were significantly associated with higher placebo response rates. The study suggests considering entry criteria based on symptom severity and separate reporting of core FD symptoms in future trials.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety

M. H. Simon, P. E. Heenan, C. Frampton, S. Bayer, J. Keenan, de N. K. Boer, N. C. Roy, N. J. Talley, R. B. Gearry

Summary: This study examines the association between functional gastrointestinal disorders (FGIDs) and depression and anxiety, and identifies the covariates influencing this association. The study finds that economic standard of living, pain, and IBS phenotype are significant independent factors associated with depression and anxiety in FGID cases.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials

Michael P. Jones, Liam Guthrie-Lyons, Yuri A. Sato, Nicholas J. Talley

Summary: Controlling for placebo effects is crucial for accurately estimating the effect of therapy. This study aimed to identify risk factors and suggest trial design changes to minimize the placebo effect in functional dyspepsia treatment trials.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Letter Gastroenterology & Hepatology

High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate-Severe Abdominal Symptoms: A Prospective US Multisite Study

Nicholas J. Talley, Kathryn A. Peterson, Robert M. Genta, Alan T. Chang, Evan S. Dellon, William J. Sandborn

GASTROENTEROLOGY (2023)

Editorial Material Medicine, General & Internal

Welcoming the new MJA Editor-in-Chief, and the top ten original research articles in the MJA in 2022

Nicholas J. Talley

MEDICAL JOURNAL OF AUSTRALIA (2023)

Letter Gastroenterology & Hepatology

Letter: childhood recurrent abdominal pain is associated with increased duodenal eosinophilia independent of Helicobacter pylori infection

Lucas Wauters, Paul R. Harris, Marjorie M. Walker, Carolina A. Serrano, Andrea Villagran, Gurpreet S. Rakhra, Jean E. Crabtree, Nicholas J. Talley

Summary: This article is connected to the paper by Broeders et al. To access this article, visit the provided link.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Review Medicine, General & Internal

Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review

Brandon Stretton, Joshua Kovoor, Stephen Bacchi, Shantel Chang, Benjamin Ngoi, Tess Murray, Thomas C. Bristow, Jonathan Heng, Aashray Gupta, Christopher Ovenden, Guy Maddern, Campbell H. Thompson, Leonie Heilbronn, Mark Boyd, Christopher Rayner, Nicholas J. Talley, Michael Horowtiz

Summary: This review summarizes the direct comparisons between subcutaneous semaglutide and other GLP-1 RAs in individuals with type 2 diabetes, focusing on their efficacy for inducing weight loss and improving metabolic health markers. Five studies which fulfilled the inclusion criteria were identified. Randomized trials support the superior efficacy of semaglutide over other GLP-1 RAs in terms of weight loss, but tirzepatide is more effective than semaglutide.

INTERNAL MEDICINE JOURNAL (2023)

Review Gastroenterology & Hepatology

Does the microbiome play a role in the pathogenesis of colonic diverticular disease? A systematic review

Raquel Cameron, Kerith Duncanson, Emily C. Hoedt, Guy D. Eslick, Grace L. Burns, Cheenie Nieva, Simon Keely, Marjorie M. Walker, Nicholas J. Talley

Summary: This systematic review assessed the association between the microbiota and metabolome in diverticulosis, symptomatic uncomplicated diverticular disease (SUDD), and diverticulitis pathophysiology. The findings suggest that there is no convincing evidence of microbial dysbiosis in colonic diverticula to suggest that the microbiota contributes to the pathogenesis of diverticulosis, SUDD, or diverticular disease.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Concentrations of Plasma Amino Acids and Neurotransmitters in Participants with Functional Gut Disorders and Healthy Controls

Shanalee C. James, Karl Fraser, Janine Cooney, Catrin S. Guenther, Wayne Young, Richard B. Gearry, Phoebe E. Heenan, Tania Trower, Jacqueline I. Keenan, Nicholas J. Talley, Warren C. McNabb, Nicole C. Roy

Summary: This study aimed to compare the circulating concentrations of amino acids and neurotransmitters between healthy participants and those with functional gastrointestinal disorders (FGIDs). The results showed significant differences in branched-chain amino acids, ornithine, and alpha-aminobutyric acid between healthy controls and FGID groups. No other significant differences were observed for the neurotransmitters or any other amino acids analyzed.

METABOLITES (2023)

Article Gastroenterology & Hepatology

Increased mucosal eosinophils in colonic diverticulosis and diverticular disease

Raquel Cameron, Marjorie M. Walker, Michael Jones, Guy D. Eslick, Simon Keely, Peter Pockney, Carolina C. Cosentino, Nicholas J. Talley

Summary: This study examined the changes of eosinophils and other immune cells in the mucosa of colonic diverticula through quantitative histology. The results showed a significant increase in eosinophil counts at the base and neck of the diverticula. These findings provide new clues for understanding the role of eosinophils and chronic inflammation in the pathophysiology of colonic diverticulosis.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Overlap of disorders of gut-brain interaction: a systematic review and

Thomas Fairlie, Ayesha Shah, Nicholas J. Talley, William D. Chey, Natasha Koloski, Yeong Yeh Lee, Kok-Ann Gwee, Michael P. Jones, Gerald Holtmann

Summary: This systematic review and meta-analysis aimed to determine the prevalence of DGBI overlap and compare the overlap in different healthcare settings. It also aimed to assess the severity of psychological comorbidities in DGBI with and without overlap.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

暂无数据